Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cyclacel Pharmaceuticals, Inc. - Common Stock (NQ:CYCC)

6.365 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cyclacel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Earnings Outlook For Cyclacel Pharmaceuticals ↗
 
Via Benzinga
News headline image
Cyclacel Pharmaceuticals's Earnings Outlook ↗
 
Via Benzinga
News headline image
Recap: Cyclacel Pharmaceuticals Q1 Earnings ↗
 
Via Benzinga
News headline image
Oppenheimer Maintains Outperform Rating for Cyclacel Pharmaceuticals: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 37,458.12 while the NASDAQ rose... 
Via Benzinga
Topics Economy Stocks
News headline image
Why Cyclacel Pharmaceuticals (CYCC) Shares Are Getting Obliterated ↗
Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares are trading lower by 26.9% to $2.63 Friday morning after the company announced it finalized an agreement to sell 388,200 shares of its common stock at... 
Via Benzinga
News headline image
CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q1 2023 ↗
CYCC stock results show that Cyclacel Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2023. 
Via InvestorPlace
News headline image
CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q2 2023 ↗
CYCC stock results show that Cyclacel Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2023. 
Via InvestorPlace
News headline image
CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q3 2023 ↗
CYCC stock results show that Cyclacel Pharmaceuticals missed analyst estimates for earnings per share the third quarter of 2023. 
Via InvestorPlace
News headline image
A Preview Of Cyclacel Pharmaceuticals's Earnings ↗
 
Via Benzinga
News headline image
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗
Shares of Salesforce, Inc. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers for Tuesday morning with all of the latest news you need to know today! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket ↗
Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2023 ↗
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740. 
Via Benzinga
News headline image
Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Tuesday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Outlook For Cyclacel Pharmaceuticals ↗
Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
News headline image
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning! 
Via InvestorPlace
News headline image
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. 
Via Benzinga
News headline image
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.